Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel methylation signature predicts inferior outcome of patients with PDAC.

Aging - 10 Jan 2021

Gu Minqi, Sun Jing, Zhang Shunhao, Chen Jing, Wang Guihua, Ju Shaoqing, Wang Xudong

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) will become the second most common cause of death in North America and Europe over the next 10 years owing to the lack of early diagnosis, poor treatment, and poor prognosis. This study evaluated the methylation array data of 184 patients with PDAC in The Cancer Genome Atlas database to explore methylation biomarkers related to patient outcome. Using Univariable Cox...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to DNA Methylation
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heme Oxygenase (Decyclizing)

Share to Integrin beta3

Share to Pancreatic Neoplasms

Share to Sensitivity and Specificity

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 33550277
DOI: 10.18632/aging.202347
PMCID: PMC7880369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel methylation signature predicts inferior outcome of patients with PDAC.PMID 33550277Read ↗

A novel epigenetic signature for predicting the prognosis of pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic CancerSemantic proximity Read ↗

Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancerSemantic proximity Read ↗

Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancerSemantic proximity Read ↗

Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancerSemantic proximity Read ↗

An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancerSemantic proximity Read ↗

Machine Learning-Based Identification of Survival-Associated CpG Biomarkers in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patientsSemantic proximity Read ↗

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

DNA methylation profile to aid in the diagnosis of pancreatic ductal adenocarcinoma and its role in disease progressionSemantic proximity Read ↗

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.